npj VaccinesMicrobiologyPeer-reviewed journal article
Multivalent administration of dengue E dimers on liposomes elicits type-specific neutralizing responses without immune interference
Thanh T.N. PhaniD, Devina ThionoiD, Matthew G. HvastaiD, Ruby P. Shah, Gisselle Prida Ajo, Wei‐Chiao HuangiD, Jonathan F. LovelliD, Shaomin TianiD, Aravinda M. de SilvaiD, Brian A. KuhlmaniD
Abstract
The four serotypes of dengue virus (DENV1-4) are a major health concern putting 50% of the global population at risk of infection. Crucially, DENV vaccines must be tetravalent to provide protection against all four serotypes because immunity to only one serotype can enhance infections caused by heterologous serotypes. Uneven replication of live-attenuated viruses in tetravalent vaccines can lead to disease enhancement instead of protection. Subunit vaccines are a promising alternative as the vaccine components are not dependent on viral replication and antigen doses can be controlled to achieve a balanced response. Here, we show that a tetravalent subunit vaccine of dengue envelope (E) proteins computationally stabilized to form native-like dimers elicits type-specific neutralizing antibodies in mice against all four serotypes. The immune response was enhanced by displaying the E dimers on liposomes embedded with adjuvant, and no interference was detected between the four components.
- organism: mouse
- assay: protein structure
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 6
- FWCI
- 4.46
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Stabilized dengue virus 2 envelope subunit vaccine redirects the neutralizing antibody response to all E-domains
Devina Thiono, Demetrios Samaras, … Aravinda M. de Silva·Journal of VirologyPeer-reviewed·Apr 16, 2025
- A dengue monovalent vaccine with novel structure provides cross-protection against four serotypes of dengue virus
Day-Yu Chao, Wen-Fan Shen, … Shang-Rung Wu·bioRxiv·Mar 5, 2018
- A Tetravalent Dengue Virus-like Particle Vaccine Induces High levels of Neutralizing Antibodies and Inhibits Dengue Replication in Non-Human Primates
D. Thoresen, K. Matsuda, … W. akahata·bioRxiv·Oct 16, 2023
- Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
L. White, E. Young, … A. De Silva·bioRxiv·Sep 23, 2020
- Design of a novel epitope-based tetravalent subunit vaccine against dengue virus: an immunoinformatics approach
Tanbin Jahan Ferdousy, Md Mehedy Hasan Miraz, … Sukalyan Kumar Kundu·PLoS ONEPeer-reviewed·Jul 28, 2026
- An epitope-resurfaced virus-like particle can induce broad neutralizing antibody against four serotypes of dengue virus
Wen-Fan Shen, Jedhan Ucat Galula, … Day-Yu Chao·bioRxiv·Jun 20, 2018